Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Ambar Protein
Join Channel
Consolidated Standalone

Ambar Protein

₹160 0.8 | 0.5%

Market Cap ₹92 Cr.

Stock P/E 19.9

P/B 3.6

Current Price ₹160

Book Value ₹ 44.4

Face Value 10

52W High ₹252.6

Dividend Yield 0%

52W Low ₹ 140

Edit Ratio

Ambar Protein Research see more...

Overview Inc. Year: 1992Industry: Edible Oil

Ambar Protein Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Ambar Protein Quarterly Results

#(Fig in Cr.) Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 82 73 95 91 84 76 95 93 69 86
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 82 73 95 91 84 76 95 93 69 86
Total Expenditure 80 71 95 85 82 74 92 91 67 82
Operating Profit 2 2 0 6 3 2 3 3 2 4
Interest 1 1 1 1 1 1 1 1 1 1
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 -1 5 2 1 2 2 1 3
Provision for Tax 0 0 -0 1 0 0 1 0 0 1
Profit After Tax 1 1 -1 4 1 0 1 1 1 2
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 1 -1 4 1 0 1 1 1 2
Adjusted Earnings Per Share 1.3 1.2 -1 6.2 2.3 0.8 1.8 2.2 1.4 2.7

Ambar Protein Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 89 160 157 168 195 206 231 284 313 340 345 343
Other Income 0 0 1 0 1 1 0 0 0 1 1 0
Total Income 90 160 158 169 196 207 231 285 314 340 346 343
Total Expenditure 89 159 155 167 193 203 227 278 306 331 338 332
Operating Profit 1 1 2 2 3 4 4 7 8 10 8 12
Interest 1 1 1 1 1 1 1 3 3 3 3 4
Depreciation 1 1 0 0 0 0 0 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -1 0 2 1 2 3 3 3 4 6 4 8
Provision for Tax 0 0 0 1 0 1 1 2 1 1 1 2
Profit After Tax -1 0 2 1 2 2 2 1 3 4 3 5
Adjustments 0 0 0 0 0 0 0 0 0 -0 0 0
Profit After Adjustments -1 0 2 1 2 2 2 1 3 4 3 5
Adjusted Earnings Per Share -1 0.1 2.7 1.5 4.2 3.7 3.5 2.2 6 7.7 4.9 8.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 1% 7% 11% 15%
Operating Profit CAGR -20% 5% 15% 23%
PAT CAGR -25% 44% 8% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -35% 184% 87% NA%
ROE Average 14% 22% 20% 25%
ROCE Average 13% 16% 15% 16%

Ambar Protein Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 2 2 4 6 6 8 10 11 15 19 22
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 4 5 4 4 3 2
Other Non-Current Liabilities 2 0 0 -1 2 1 3 4 3 3 3
Total Current Liabilities 9 11 9 11 15 18 36 31 29 39 35
Total Liabilities 14 13 13 17 23 31 53 49 50 64 62
Fixed Assets 5 4 4 6 6 6 7 22 21 21 20
Other Non-Current Assets 1 0 0 0 0 6 16 0 0 0 0
Total Current Assets 8 8 8 10 17 19 31 27 29 43 42
Total Assets 14 13 13 17 23 31 53 49 50 64 62

Ambar Protein Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 1 2 1 2 3 1 2 1 1
Cash Flow from Operating Activities -2 6 1 -1 -3 1 1 3 1 -3 6
Cash Flow from Investing Activities -0 0 0 -1 0 -5 -10 -1 -0 -0 0
Cash Flow from Financing Activities 2 -6 -1 1 3 6 7 -0 -2 2 -6
Net Cash Inflow / Outflow -0 0 0 -1 1 1 -2 1 -1 -0 0
Closing Cash & Cash Equivalent 0 0 2 1 2 3 1 2 1 1 1

Ambar Protein Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -0.99 0.14 2.7 1.51 4.19 3.75 3.54 2.17 6 7.74 4.89
CEPS(Rs) 0 1.15 3.12 1.91 4.54 4.18 3.99 4.14 8.09 9.97 7.11
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 2.05 1.21 4.24 8.48 10.02 13.77 17.31 19.48 25.48 33.21 38.13
Core EBITDA Margin(%) 0.32 0.55 1.09 1.16 1.29 1.47 1.68 2.12 2.35 2.7 2.09
EBIT Margin(%) 0.13 0.45 1.41 1.16 1.62 1.78 1.75 1.89 2.11 2.53 1.88
Pre Tax Margin(%) -0.64 0.05 0.99 0.81 1.26 1.42 1.23 0.97 1.27 1.74 1.15
PAT Margin (%) -0.64 0.05 0.99 0.52 1.23 1.05 0.88 0.44 1.1 1.31 0.82
Cash Profit Margin (%) 0 0.41 1.14 0.65 1.34 1.17 0.99 0.84 1.48 1.69 1.18
ROA(%) -4.49 0.58 11.86 5.91 12.14 7.99 4.85 2.43 6.93 7.78 4.45
ROE(%) -38.9 8.36 99.23 23.82 45.24 31.5 22.76 11.79 26.69 26.38 13.72
ROCE(%) 1.19 8.37 27.73 18.69 22.17 17.45 13.38 14.84 16.53 18.33 12.59
Receivable days 2.84 2.98 2.53 2.32 5.35 5.23 2.29 2.26 3.23 6.74 12.35
Inventory Days 21.04 11.25 10.35 13.12 15.9 15.67 23.69 23.06 18.48 23.68 24.41
Payable days 5.14 8.3 11.62 10.14 9.37 7.22 7.64 5.83 3.83 6.44 7.87
PER(x) 0 0 0 0 0 0 0 0 0 3.83 43.81
Price/Book(x) 0 0 0 0 0 0 0 0 0 0.89 5.62
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.16 0.07 0.06 0.07 0.07 0.1 0.13 0.1 0.1 0.14 0.44
EV/Core EBITDA(x) 20.17 9.07 3.98 5.61 4.2 5.2 6.77 4.57 4.02 4.9 19.5
Net Sales Growth(%) -22.02 79.21 -2.02 7.41 15.89 5.52 11.9 23.34 10.18 8.44 1.57
EBIT Growth(%) -90.69 509.83 205.49 -11.32 61.81 15.48 9.92 33.77 23.04 29.8 -24.52
PAT Growth(%) -366.3 113.75 1881.54 -43.94 176.34 -10.49 -5.62 -38.69 176.65 29.02 -36.78
EPS Growth(%) -366.3 113.75 1881.53 -43.94 176.35 -10.49 -5.62 -38.69 176.65 29.03 -36.78
Debt/Equity(x) 3.23 3.02 1.38 1.07 1.8 2.26 2.45 2.41 1.86 1.72 1.34
Current Ratio(x) 0.83 0.73 0.86 0.92 1.1 1.06 0.86 0.88 1 1.11 1.19
Quick Ratio(x) 0.24 0.31 0.37 0.23 0.49 0.59 0.26 0.41 0.4 0.43 0.64
Interest Cover(x) 0.17 1.12 3.37 3.34 4.42 5.04 3.38 2.05 2.51 3.2 2.56
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 1.92 0.24

Ambar Protein Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 74.97 74.97 74.97 70.35 70.35 70.46 70.46 70.46 70.46 70.73
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 25.03 25.03 25.03 29.65 29.65 29.54 29.54 29.54 29.54 29.27
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 22%
  • Company has reduced debt.

Cons

  • Debtor days have increased from 6.44 to 7.87days.
  • Stock is trading at 3.6 times its book value.
  • The company has delivered a poor profit growth of 8% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Ambar Protein News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!